As of June 30, 2026, Jenscare Scientific Co. Ltd. Class H carries a market capitalization of 3.02B, placing it among publicly traded companies globally. Its enterprise value stands at 2.57B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 3.02B |
| Enterprise Value | 2.57B |
Jenscare Scientific Co. Ltd. Class H's next confirmed earnings release is scheduled for March 31, 2027.
| Earnings Date | 3/31/2027 |
As of June 30, 2026, Jenscare Scientific Co. Ltd. Class H has 417.17M shares outstanding.
| Shares Outstanding | 417.17M |
These figures are as of June 30, 2026.
| PB Ratio | 3.49 |
| P/TBV Ratio | 3.51 |
As of June 30, 2026, Jenscare Scientific Co. Ltd. Class H maintains a current ratio of 6.98, meaning it holds 7.0x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 6.98 |
| Quick Ratio | 5.26 |
| Debt / Equity | 5.41 |
These figures cover the twelve months ended June 30, 2026.
| Employee Count | 195.00 |
As of the close on November 17, 2026, Jenscare Scientific Co. Ltd. Class H's stock has declined approximately 43.99% over the past 52 weeks. The 50-day moving average sits at 6.90, while the 200-day moving average is 7.84.
| 52-Week Price Change | -43.99% |
| 50-Day Moving Average | 6.90 |
| 200-Day Moving Average | 7.84 |
As of June 30, 2026, Jenscare Scientific Co. Ltd. Class H holds 479.21M in cash and equivalents against 45.87M in total debt, resulting in a net debt position of -420.63M. Total book value stands at 867.48M, with working capital of 544.14M providing operational flexibility.
| Cash & Cash Equivalents | 479.21M |
| Total Debt | 45.87M |
| Net Debt | -420.63M |
| Equity (Book Value) | 867.48M |
| Book Value Per Share | 2.08 |
| Working Capital | 544.14M |
Already premium?